In the era of highly effective direct acting antiviral(DAA) drugs for the treatment of chronic hepatitis C(CHC) infection, where eradication is almost ensured w
Hepatocellular carcinoma (HCC) is the leading primaryliver cancer and its clinical outcome is still poor. MicroRNAs(miRNAs) have demonstrated an interestingpotentia